RARE logo

RARE Interest expense

annual interest expense:

$63.04M-$2.96M(-4.49%)
December 31, 2024

Summary

  • As of today (July 7, 2025), RARE annual interest expense is $63.04 million, with the most recent change of -$2.96 million (-4.49%) on December 31, 2024.
  • During the last 3 years, RARE annual interest expense has risen by +$33.62 million (+114.26%).
  • RARE annual interest expense is now -4.49% below its all-time high of $66.00 million, reached on December 31, 2023.

Performance

RARE Interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRAREincome statement metrics

quarterly interest expense:

$14.34M-$1.18M(-7.60%)
March 31, 2025

Summary

  • As of today (July 7, 2025), RARE quarterly interest expense is $14.34 million, with the most recent change of -$1.18 million (-7.60%) on March 31, 2025.
  • Over the past year, RARE quarterly interest expense has dropped by -$1.50 million (-9.50%).
  • RARE quarterly interest expense is now -18.81% below its all-time high of $17.66 million, reached on September 30, 2023.

Performance

RARE quarterly interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRAREincome statement metrics

TTM interest expense:

$61.54M-$1.50M(-2.39%)
March 31, 2025

Summary

  • As of today (July 7, 2025), RARE TTM interest expense is $61.54 million, with the most recent change of -$1.50 million (-2.39%) on March 31, 2025.
  • Over the past year, RARE TTM interest expense has dropped by -$4.68 million (-7.07%).
  • RARE TTM interest expense is now -7.88% below its all-time high of $66.80 million, reached on June 30, 2024.

Performance

RARE TTM interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRAREincome statement metrics

Interest expense Formula

Interest Expense = Carrying Value of Debt X Effective Interest Rate

RARE Interest expense Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-4.5%-9.5%-7.1%
3 y3 years+114.3%+117.8%+123.0%
5 y5 years+5454.3%+77.5%+248.7%

RARE Interest expense Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-4.5%+114.3%-18.8%+137.0%-7.9%+144.9%
5 y5-year-4.5%+5454.3%-18.8%+277.0%-7.9%+248.7%
alltimeall time-4.5%>+9999.0%-18.8%>+9999.0%-7.9%>+9999.0%

RARE Interest expense History

DateAnnualQuarterlyTTM
Mar 2025
-
$14.34M(-7.6%)
$61.54M(-2.4%)
Dec 2024
$63.04M(-4.5%)
$15.52M(-1.2%)
$63.04M(-2.8%)
Sep 2024
-
$15.71M(-1.6%)
$64.85M(-2.9%)
Jun 2024
-
$15.96M(+0.7%)
$66.80M(+0.9%)
Mar 2024
-
$15.85M(-8.5%)
$66.22M(+0.3%)
Dec 2023
$66.00M(+53.4%)
$17.33M(-1.9%)
$66.00M(+2.3%)
Sep 2023
-
$17.66M(+14.9%)
$64.55M(+5.1%)
Jun 2023
-
$15.38M(-1.7%)
$61.39M(+17.9%)
Mar 2023
-
$15.64M(-1.5%)
$52.07M(+21.0%)
Dec 2022
$43.02M(+46.2%)
$15.87M(+9.4%)
$43.02M(+39.0%)
Sep 2022
-
$14.51M(+139.7%)
$30.95M(+23.2%)
Jun 2022
-
$6.05M(-8.1%)
$25.12M(-8.9%)
Mar 2022
-
$6.58M(+73.1%)
$27.59M(-6.2%)
Dec 2021
$29.42M
$3.80M(-56.2%)
$29.42M(-13.0%)
DateAnnualQuarterlyTTM
Sep 2021
-
$8.68M(+1.9%)
$33.82M(+0.3%)
Jun 2021
-
$8.52M(+1.2%)
$33.72M(+0.3%)
Mar 2021
-
$8.42M(+2.7%)
$33.63M(+1.0%)
Dec 2020
$33.29M(+2833.1%)
$8.20M(-4.5%)
$33.29M(+26.9%)
Sep 2020
-
$8.58M(+1.8%)
$26.23M(+48.6%)
Jun 2020
-
$8.43M(+4.3%)
$17.65M(+91.5%)
Mar 2020
-
$8.08M(+612.1%)
$9.22M(+712.1%)
Dec 2019
$1.14M(>+9900.0%)
$1.14M(>+9900.0%)
$1.14M(>+9900.0%)
Sep 2019
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2019
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2019
-
$0.00
$0.00
Dec 2018
$0.00(0.0%)
-
-
Dec 2017
$0.00(-100.0%)
-
-
Dec 2011
$270.00K
-
-

FAQ

  • What is Ultragenyx Pharmaceutical Inc. annual interest expense?
  • What is the all time high annual interest expense for Ultragenyx Pharmaceutical Inc.?
  • What is Ultragenyx Pharmaceutical Inc. annual interest expense year-on-year change?
  • What is Ultragenyx Pharmaceutical Inc. quarterly interest expense?
  • What is the all time high quarterly interest expense for Ultragenyx Pharmaceutical Inc.?
  • What is Ultragenyx Pharmaceutical Inc. quarterly interest expense year-on-year change?
  • What is Ultragenyx Pharmaceutical Inc. TTM interest expense?
  • What is the all time high TTM interest expense for Ultragenyx Pharmaceutical Inc.?
  • What is Ultragenyx Pharmaceutical Inc. TTM interest expense year-on-year change?

What is Ultragenyx Pharmaceutical Inc. annual interest expense?

The current annual interest expense of RARE is $63.04M

What is the all time high annual interest expense for Ultragenyx Pharmaceutical Inc.?

Ultragenyx Pharmaceutical Inc. all-time high annual interest expense is $66.00M

What is Ultragenyx Pharmaceutical Inc. annual interest expense year-on-year change?

Over the past year, RARE annual interest expense has changed by -$2.96M (-4.49%)

What is Ultragenyx Pharmaceutical Inc. quarterly interest expense?

The current quarterly interest expense of RARE is $14.34M

What is the all time high quarterly interest expense for Ultragenyx Pharmaceutical Inc.?

Ultragenyx Pharmaceutical Inc. all-time high quarterly interest expense is $17.66M

What is Ultragenyx Pharmaceutical Inc. quarterly interest expense year-on-year change?

Over the past year, RARE quarterly interest expense has changed by -$1.50M (-9.50%)

What is Ultragenyx Pharmaceutical Inc. TTM interest expense?

The current TTM interest expense of RARE is $61.54M

What is the all time high TTM interest expense for Ultragenyx Pharmaceutical Inc.?

Ultragenyx Pharmaceutical Inc. all-time high TTM interest expense is $66.80M

What is Ultragenyx Pharmaceutical Inc. TTM interest expense year-on-year change?

Over the past year, RARE TTM interest expense has changed by -$4.68M (-7.07%)
On this page